Hyperpigmentation Disorders Treatment Market Research Report Information By Treatment Type (Tropical Drugs, Chemical Peels, and Lesar Therapy), By Disease Indication (Melasma and Solar Lentigines), By End User (Hospitals and others),and By Region (North America, Asia-Pacific, Europe, And Rest Of The World) – Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Hyperpigmentation Disorders Treatment Market, by Treatment Type

6.1 Introduction

6.2 Topical Drugs

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.3 Chemical Peels

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.4 Microdermabrasion

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.5 Laser Therapy

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.6 Phototherapy

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

6.7 Others

Chapter 7. Global Hyperpigmentation Disorders Treatment Market, by Disease Indication

7.1 Introduction

7.2 Melasma

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3 Solar Lentigines

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3 Post-inflammatory Hyperpigmentation

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

7.3 Others

Chapter 8. Global Hyperpigmentation Disorders Treatment Market, by End-User

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.3 Aesthetic Clinics & Dermatology Centers

Market Estimates & Forecast, by Region, 2023–2030

Market Estimates & Forecast, by Country, 2023–2030

8.4 Others

Chapter 9. Global Hyperpigmentation Disorders Treatment Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 12. Company Landscape

12.1 Introduction

12.2 Market Share Analysis

12.3 Key Development & Strategies

Chapter 13. Company Profiles

13.1 Allergan, Inc.

13.1.1 Company Overview

13.1.2 Product Overview

13.1.3 Financials Overview

13.1.4 Key Developments

13.1.5 SWOT Analysis

13.2 Bayer AG

13.2.1 Company Overview

13.2.2 Product Overview

13.2.3 Financial Overview

13.2.4 Key Developments

13.2.5 SWOT Analysis

13.3 EpiPharm AG

13.3.1 Company Overview

13.3.2 Product Overview

13.3.3 Financial Overview

13.3.4 Key Development

13.3.5 SWOT Analysis

13.4 Episciences, Inc.

13.4.1 Company Overview

13.4.2 Technologys/Business Segment Overview

13.4.3 Financial Overview

13.4.4 Key Development

13.4.5 SWOT Analysis

13.5 Galderma laboratories (Nestle Skin Health S.A)

13.5.1 Company Overview

13.5.2 Product Overview

13.5.3 Financial overview

13.5.4 Key Developments

13.5.5 SWOT Analysis

13.6 Obagi Cosmeceuticals LLC

13.6.1 Company Overview

13.6.2 Product Overview

13.6.3 Financial Overview

13.6.4 Key Developments

13.6.5 SWOT Analysis

13.7 Pierre Fabre

13.7.1 Overview

13.7.2 Product Overview

13.7.3 Financial Overview

13.7.4 Key Developments

13.7.5 SWOT Analysis

13.8 RXi Pharmaceuticals Corporation

13.8.1 Overview

13.8.2 Product/ Technology Overview

13.8.3 Financials

13.8.4 Key Developments

13.8.5 SWOT Analysis

13.9 SkinCeuticals International

13.9.1 Overview

13.9.2 Product Overview

13.9.3 Financials

13.9.4 Key Developments

13.9.5 SWOT Analysis

13.10 Vivier Pharma

13.10.1 Overview

13.10.2 Product Overview

13.10.3 Financials

13.10.4 Key Developments

13.10.5 SWOT Analysis

13.11 Others

Chapter 14. MRFR Conclusion

14.1 Key Findings

14.1.1 From CEO’s Viewpoint

14.1.2 Unmet Needs of the Market

14.2 Key Companies to Watch

14.3 Predictions for the Hyperpigmentation Disorders Treatment Industry

Chapter 15. Appendix

LIST OF TABLES

Table 1 Global Hyperpigmentation Disorders Treatment Market Synopsis, 2023–2030

Table 2 Global Hyperpigmentation Disorders Treatment Market Estimates and Forecast, 2023–2030 (USD Million)

Table 3 Global Hyperpigmentation Disorders Treatment Market, by Region, 2023–2030 (USD Million)

Table 4 Global Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 5 Global Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 6 Global Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 7 North America: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 8 North America: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 9 North America: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 10 US: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 11 US: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 12 US: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 13 Canada: Hyperpigmentation Disorders Treatment Market,by Treatment Type, 2023–2030 (USD Million)

Table 14 Canada: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 15 Canada: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 16 South America: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 17 South America: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 18 South America: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 19 Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 20 Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 21 Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 22 Western Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 23 Western Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 24 Western Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 25 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 26 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 27 Eastern Europe: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 28 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 29 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 30 Asia-Pacific: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

Table 31 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by Treatment Type, 2023–2030 (USD Million)

Table 32 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by Disease Indication, 2023–2030 (USD Million)

Table 33 Middle East & Africa: Hyperpigmentation Disorders Treatment Market, by End-User, 2023–2030 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Hyperpigmentation Disorders Treatment Market

Figure 3 Segmentation Market Dynamics for Global Hyperpigmentation Disorders Treatment Market

Figure 4 Global Hyperpigmentation Disorders Treatment Market Share, by Treatment Type, 2023

Figure 5 Global Hyperpigmentation Disorders Treatment Market Share, by Disease Indication, 2023

Figure 6 Global Hyperpigmentation Disorders Treatment Market Share, by End-User, 2023

Figure 7 Global Hyperpigmentation Disorders Treatment Market Share, by Region, 2023

Figure 8 North America: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023

Figure 9 Europe: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023

Figure 10 Asia-Pacific: Hyperpigmentation Disorders Treatment Market Share, by Country, 2023

Figure 11 Middle East & Africa: Hyperpigmentation Disorders Treatment Market Share, by Region, 2023

Figure 12 Global Hyperpigmentation Disorders Treatment Market: Company Share Analysis, 2023 (%)

Figure 13 Allergan, Inc.: Key Financials

Figure 14 Allergan, Inc.: Segmental Revenue

Figure 15 Allergan, Inc.: Geographical Revenue

Figure 16 Bayer AG: Key Financials

Figure 17 Bayer AG: Segmental Revenue

Figure 18 Bayer AG: Geographical Revenue

Figure 19 EpiPharm AG: Key Financials

Figure 20 EpiPharm AG: Segmental Revenue

Figure 21 EpiPharm AG: Geographical Revenue

Figure 22 Episciences, Inc.: Key Financials

Figure 23 Episciences, Inc.: Segmental Revenue

Figure 24 Episciences, Inc.: Geographical Revenue

Figure 25 Galderma laboratories (Nestle Skin Health S.A): Key Financials

Figure 26 Galderma laboratories (Nestle Skin Health S.A): Segmental Revenue

Figure 27 Galderma laboratories (Nestle Skin Health S.A): Geographical Revenue

Figure 28 Obagi Cosmeceuticals LLC: Key Financials

Figure 29 Obagi Cosmeceuticals LLC: Segmental Revenue

Figure 30 Obagi Cosmeceuticals LLC: Geographical Revenue

Figure 31 Pierre Fabre: Key Financials

Figure 32 Pierre Fabre: Segmental Revenue

Figure 33 Pierre Fabre: Geographical Revenue

Figure 34 Pierre Fabre: Key Financials

Figure 35 Pierre Fabre: Segmental Revenue

Figure 36 Pierre Fabre: Geographical Revenue

Figure 37 SkinCeuticals International: Key Financials

Figure 38 SkinCeuticals International: Segmental Revenue

Figure 39 SkinCeuticals International: Geographical Revenue

Figure 40 Vivier Pharma: Key Financials

Figure 41 Vivier Pharma: Segmental Revenue

Figure 42 Vivier Pharma: Geographical Revenue